Risk Factors for Radiation Necrosis and Local Recurrence after Proton Beam Therapy for Skull Base Chordoma or Chondrosarcoma

被引:4
作者
Takahashi, Mizuki [1 ]
Mizumoto, Masashi [1 ]
Oshiro, Yoshiko [2 ]
Kino, Hiroyoshi [3 ]
Akutsu, Hiroyoshi [4 ]
Nakai, Kei [1 ]
Sumiya, Taisuke [1 ]
Ishikawa, Eiichi [3 ]
Maruo, Kazushi [5 ]
Sakurai, Hideyuki [1 ]
机构
[1] Univ Tsukuba, Dept Radiat Oncol, Tsukuba, Ibaraki 3058575, Japan
[2] Tsukuba Med Ctr Hosp, Dept Radiat Oncol, Tsukuba, Ibaraki 3058558, Japan
[3] Univ Tsukuba, Inst Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan
[4] Dokkyo Med Univ, Dept Neurosurg, Mibu, Tochigi 3210293, Japan
[5] Univ Tsukuba, Inst Med, Dept Biostat, Tsukuba, Ibaraki 3058576, Japan
关键词
chordoma; chondrosarcoma; radiotherapy; proton beam therapy; brain necrosis; CARBON ION RADIOTHERAPY; PROGNOSTIC-FACTORS; CRANIAL BASE; FOLLOW-UP; OUTCOMES; RADIOSURGERY; MANAGEMENT; VOLUME; SPINE;
D O I
10.3390/cancers15235687
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[Proposal] Here, we retrospectively evaluate risk factors for radiation necrosis and local recurrence after PBT for skull base chordoma or chondrosarcoma. [Patients and Methods] We analyzed 101 patients who received PBT for skull base chordomas and chondrosarcomas from January 1989 to February 2021. Multivariable logistic regression models were applied for local recurrence, temporal lobe radiation necrosis rates, and temporal lobe radiation necrosis. [Results] In multivariate analysis, chordoma and large tumor size were independent significant factors for local recurrence. The 1-, 2-, 3-, 4- and 5-year local recurrence rates were 3.9%, 16.9%, 20.3%, 28.5% and 44.0% for chordoma and 0%, 0%, 0%, 0% and 7.1% for chondrosarcoma, respectively. The local recurrence rates of small tumors (<30 mm) were 4.3%, 14.7%, 17.7%, 17.7% and 25.9%, and those for large tumors were 3.6%, 15.1%, 19.2%, 32.7% and 59.6%, respectively. In multivariate analysis, BED Gy(10) and total dose were risk factors for radiation necrosis. [Conclusions] For skull base chordoma and chondrosarcoma, the risk factors of local recurrence were chordoma and large tumor size, and those of radiation necrosis were BED Gy(10) and total dose, respectively. DVH analysis is needed to investigate the risk factors for brain necrosis in more detail.
引用
收藏
页数:13
相关论文
共 50 条
[21]   Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates [J].
Pahwa, Bhavya ;
Medani, Khalid ;
Lu, Victor M. ;
Elarjani, Turki .
NEUROSURGICAL REVIEW, 2022, 45 (06) :3551-3563
[22]   Hypofractionated stereotactic radiation therapy for skull base and upper cervical chordoma and chondrosarcoma: Preliminary results [J].
Gwak, HS ;
Yoo, HJ ;
Youn, SM ;
Changa, UK ;
Lee, DH ;
Yoo, SY ;
Rhee, CH .
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY, 2005, 83 (5-6) :233-243
[23]   Systematic Review and Meta-Analysis of Particle Beam Therapy versus Photon Radiotherapy for Skull Base Chordoma: TRP-Chordoma 2024 [J].
Saito, Takashi ;
Mizumoto, Masashi ;
Oshiro, Yoshiko ;
Shimizu, Shosei ;
Li, Yinuo ;
Nakamura, Masatoshi ;
Hosaka, Sho ;
Nakai, Kei ;
Iizumi, Takashi ;
Inaba, Masako ;
Fukushima, Hiroko ;
Suzuki, Ryoko ;
Maruo, Kazushi ;
Sakurai, Hideyuki .
CANCERS, 2024, 16 (14)
[24]   Radiation Strategies for Spine Chordoma Proton Beam, Carbon Ions, and Stereotactic Body Radiation Therapy [J].
Konieczkowski, David J. ;
DeLaney, Thomas F. ;
Yamada, Yoshiya .
NEUROSURGERY CLINICS OF NORTH AMERICA, 2020, 31 (02) :263-+
[25]   Tumour Volume and Dose Influence Outcome after Surgery and Highdose Photon Radiotherapy for Chordoma and Chondrosarcoma of the Skull Base and Spine [J].
Gatfield, E. R. ;
Noble, D. J. ;
Barnett, G. C. ;
Early, N. Y. ;
Hoole, A. C. F. ;
Kirkby, N. F. ;
Jefferies, S. J. ;
Burnet, N. G. .
CLINICAL ONCOLOGY, 2018, 30 (04) :243-253
[26]   Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study [J].
Holtzman, Adam L. ;
Rotondo, Ronny L. ;
Rutenberg, Michael S. ;
Indelicato, Daniel J. ;
Mercado, Catherine E. ;
Rao, Dinesh ;
Tavanaiepour, Daryoush ;
Morris, Christopher G. ;
Louis, Debbie ;
Flampouri, Stella ;
Mendenhall, William M. .
JOURNAL OF NEURO-ONCOLOGY, 2019, 142 (03) :557-563
[27]   Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan [J].
Demizu, Yusuke ;
Mizumoto, Masashi ;
Onoe, Tsuyoshi ;
Nakamura, Naoki ;
Kikuchi, Yasuhiro ;
Shibata, Tetsushi ;
Okimoto, Tomoaki ;
Sakurai, Hideyuki ;
Akimoto, Tetsuo ;
Ono, Kota ;
Daimon, Takashi ;
Murayama, Shigeyuki .
CANCER SCIENCE, 2017, 108 (05) :972-977
[28]   Factors Predicting Recurrence After Resection of Clival Chordoma Using Variable Surgical Approaches and Radiation Modalities [J].
Jahangiri, Arman ;
Chin, Aaron T. ;
Wagner, Jeffrey R. ;
Kunwar, Sandeep ;
Ames, Christopher ;
Chou, Dean ;
Barani, Igor ;
Parsa, Andrew T. ;
McDermott, Michael W. ;
Benet, Arnau ;
El-Sayed, Ivan H. ;
Aghi, Manish K. .
NEUROSURGERY, 2015, 76 (02) :179-185
[29]   A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base [J].
Maurizio Amichetti ;
Dante Amelio ;
Marco Cianchetti ;
Riccardo Maurizi Enrici ;
Giuseppe Minniti .
Neurosurgical Review, 2010, 33 :155-165
[30]   Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy [J].
Weber, Damien C. ;
Malyapa, Robert ;
Albertini, Francesca ;
Bolsi, Alessandra ;
Kliebsch, Ulrike ;
Walser, Marc ;
Pica, Alessia ;
Combescure, Christophe ;
Lomax, Antony J. ;
Schneider, Ralf .
RADIOTHERAPY AND ONCOLOGY, 2016, 120 (01) :169-174